CDC Committee Debates COVID-19 Vaccinations for Immunocompromised Individuals & Boosters

The US Centers for Disease Control and Prevention (CDC) announced a virtual COVID-19 vaccine committee meeting on August 13, 2021, at 11 a.m. ET. No registration is required, and this is the webcast link.

As of August 9, 2021, the meeting's agenda focuses on additional COVID-19 vaccine doses for immunocompromised individuals, COVID-19 epidemiology, and vaccine impact considerations for booster doses COVID-19 vaccines.

Presentations for this new Advisory Committee on Immunization Practices (ACIP) meeting, and previous meetings, can be found on this CDC webpage.

The ACIP holds meetings at the CDC in Atlanta, Georgia, to review scientific data and vote on vaccine recommendations.

The ACIP is currently chaired by José R. Romero, M.D., FAAP, FIDSA, FPIDS, FAAAS, and includes 15 voting members responsible for making vaccine recommendations. In addition to the voting members, the ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertise.

The ACIP Committee’s recommendations are forwarded to CDC’s 19th Director, Rochelle P. Walensky, M.D., MPH, for approval.